Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease plasmacytoma
Comorbidity C0026764|myeloma
Sentences 23
PubMedID- 24395149 Clinical analysis of 36 multiple myeloma patients with extramedullary plasmacytoma invasion of the spinal canal.
PubMedID- 20930442 A rare masquerader of lung cancer: nonsecretory multiple myeloma with plasmacytoma of bone presenting as acute kidney injury.
PubMedID- 26098547 Multiple myeloma has correlation with plasmacytoma, which is a mass of plasma cells found outside of bone marrow [3] that needs medical intervention with radiotherapy [4] or chemotherapy.
PubMedID- 24137282 Multiple myeloma with extramedullary plasmacytoma invading the skin and eyeballs following autologous stem cell transplantation: a case report.
PubMedID- 21498133 Subsequent histology revealed plasmacytoma associated with anaplastic multiple myeloma, and the patient was referred to the hematology department for further treatment.
PubMedID- 21322793 Fine needle biopsy and mri showed recurrence of multiple myeloma with soft tissue plasmacytoma of the extraconal region compressing the right optic nerve.
PubMedID- 22105527 Incidence of plasmacytomas associated with multiple myeloma range from 7% to 17% at diagnosis and from 6% to 20% during the course of the disease.
PubMedID- 20944171 Background: a case of relapsed multiple myeloma (mm) with multiple plasmacytomas of the parietal bone and the right orbit in which was achieved a complete response with bortezomib plus dexamethasone (bd) therapy is reported.
PubMedID- 21712927 [2] hereby, we present a case of multiple myeloma with lung plasmacytoma of lung, in a 45-years-old, non-smoker, female.
PubMedID- 25624087 We present a multiple myeloma case, with an intracranial plasmacytoma, which debuted clinically with isolated, complete and fluctuating cranial nerve iii palsy.
PubMedID- 25812994 However, there are few data about the prognostic significance of cytogenetic abnormalities for autologous stem cell transplantation (asct) in multiple myeloma (mm) patients with extramedullary plasmacytoma (emp).
PubMedID- 24813053 These results demonstrate that, even though asct achieved a strong response in myeloma patients with soft tissue plasmacytoma, the presence of em disease still contributed to a poor prognosis after asct compared to skeletal plasmacytoma, and these poor outcomes were not overcome by asct.
PubMedID- 22036139 Misdiagnosing or mislabeling symptomatic myeloma patients with plasmacytoma results in the delay of their systemic treatment.
PubMedID- 20931018 The prognosis of extramedullary plasmacytoma with multiple myeloma is poor and most patients die within 2 years of their diagnosis.
PubMedID- 19416310 Subsequent to investigations, five cases were labelled as multiple myeloma with secondary extramedullary plasmacytoma, three as solitary bone plasmacytoma and two as primary extramedullary plasmacytoma.
PubMedID- 19914061 Bone marrow neovascularisation supports plasma cell tumour progression in patients with multiple myeloma (mm), and is partially sustained by bone marrow macrophages through their angiogenic and vasculogenic activities.
PubMedID- 22738942 No clinical, laboratory, or imaging findings indicative of multiple myeloma or association with other plasmacytomas were found, so the tumor was considered to be a primary pancreatic plasmacytoma.
PubMedID- 25694834 A final diagnosis of multiple myeloma complicated with extramedullary plasmacytomas involving the pancreas, suprarenal gland, kidney, skin, lung, liver, spleen, and lymph nodes was attained.
PubMedID- 22781459 Objective: to explore the clinical features, treatment and prognosis of multiple myeloma (mm) with extramedullary plasmacytomas (em).
PubMedID- 25039116 Case report: we presented a case of multiple myeloma with lung plasmacytoma, in a 79 year-old patient, hospitalized for febrility and infiltrative mass in the right lung.
PubMedID- 23921944 Multiple myeloma with isolated plasmacytoma in temporal bone.
PubMedID- 25842207 There is a need for features that indicate likelihood of myeloma in patients with plasmacytoma without other manifestations.
PubMedID- 23152688 Objective: we studied the clinical and laboratory features and outcomes of multiple myeloma (mm) with extramedullary plasmocytoma (ep) disease both at diagnosis and during the course of mm.

Page: 1